On February 2, 2017 The Ministry of Health and Family Welfare has announced Medical Devices Rules, 2017 that separates regulatory norms for manufacturing medical devices from drugs. The rules will come into effect from January 1, 2018.

This new rules is to regulate medical devices in the country to ease norms for manufacturing medical devices in the country and to promote domestic industry. The new rules also have eased standard for obtaining license and conducting clinical trials, and also reduced interface between manufacturer and regulator by promoting digital platform.

The government has observed to the industry’s nearly decade long demand of separating it from pharmaceutical industry so that the same powerful laws that regulate drugs are not applicable to medical devices. The rules have a provision for awarding compensation up to8 lakh to people impacted by trials adversely.

The Health Ministry joint secretary KL Sharma said, “Till now medical devices were regulated as drugs but now we have separated the two and formed rules specifically catering to the medical devices industry,” Medical devices have been classified in four categories based on their risk type (Class A, B, C and D). Central government will be directly involved in approvals and licensing of devices falling under category C & D.

The industry will no longer have to follow tough clinical trial guidelines spanning 4 phases, like in case of drug trials. Only a pilot study on smaller population to test safety and performance of the device and later a trial on pivotal basis on a larger population, The rules are designed to standardize and regulate medical devices manufacturing industry, as good as international standards. The new rules have been framed in conformity with Global Harmonisation Task Force (GHTF) framework and follow best international practices.

The action will boost government’s ‘Make in India’ campaign by providing favorable environment for domestic manufacturers that could lead to greater long term investments.

HindustanTimes

Other News

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More

TGA Supports MHRA’s New Regulations

The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]

Read More

Medical Devices with Extended CE Certification Are Now Accepted On The UK Market

The MHRA revised its guidelines to make clear its stance and reflect its intention to extend the acceptance of CE-marked medical devices on the British market beyond June 30th, 2023. A statutory document that will […]

Read More

The NMPA Enhanced Regulation of Cosmetic Medicine

According to a representative of the State Administration for Market Regulation, after the industry’s quick development, prominent issues like unethical medical practices, fake goods, false advertising, and price fraud emerged, endangering the health and interests […]

Read More

Radiation Sterilization Master File Pilot Program Announced by CDRH

CDRH is establishing a Radiation Sterilization Master File Pilot Program to assist businesses in developing less troublesome regulatory methods for sterilizing licensed medical equipment, such as switching radiation sources. The pilot program, which is optional, […]

Read More